Pancreatic Cancer Research

ResearcherUniversity of HelsinkiNo recent work listed

Mira Lanki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7978-3308; OpenAlex author ID A5065750717. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 4

  1. Serum cytokine profiles in patients with pancreatic cancer and chronic pancreatitis. Co-author DOI 10.1016/j.pan.2023.07.004↗
  2. Pancreatic cancer survival prediction via inflammatory serum markers. Co-author DOI 10.1007/s00262-021-03137-6↗
  3. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0219245↗
  4. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer. Co-author DOI 10.1177/1010428318801188↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanna E. Seppänen · 4 shared papers, 2018–2023 · strength 0.60
  2. Caj H. Haglund · 4 shared papers, 2018–2023 · strength 0.60
  3. Aino Salmiheimo · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.